Private equity analysts have published a screening report identifying four publicly traded stocks that match the structural profile for leveraged buyout execution in the present rate environment. The names were not disclosed in the intelligence summary, but the publication timing aligns with industrywide pressure to deploy $2.59 trillion in committed capital sitting in North American and European PE funds as of Q1 2026.

The screen criteria typically isolate three characteristics: predictable free cash flow sufficient to service acquisition debt at current spreads, enterprise values below 8x EBITDA where leverage multiples remain financeable, and management teams either amenable to takeout or replaceable without operational interruption. Secondary filters include low capital intensity, limited cyclical exposure, and ownership structures with no controlling blockholder above 15% that could complicate tender mechanics. The screen's publication suggests at least one bulge-bracket PE advisor has begun socializing the names to fund clients ahead of formal approach.

The timing matters for two reasons. First, the 5.25% benchmark rate has compressed the bid-ask spread between public market valuations and what buyout shops can underwrite while still clearing 18-22% IRR hurdles for their LPs. Names trading below intrinsic value but above distressed levels represent the narrow band where deals pencil without requiring operational heroics post-close. Second, PE funds raised between 2021-2023 are entering their deployment windows; general partners face LP pressure to put capital to work before management fees on undeployed commitments begin eroding net returns. A public screen of this kind functions as pre-marketing, testing whether sell-side analysts and minority shareholders will support a going-private premium in the 25-35% range.

The operational implications depend on sector. If the four names include industrials or business services firms, expect approaches structured as management-partnered buyouts with equity rollovers for existing executives, closings in 90-120 days assuming HSR clearance. If any are technology or healthcare assets, timelines extend to 150-180 days for regulatory review, and deal structures shift toward majority recaps rather than full takeouts, preserving partial public floats to manage valuation risk. The screen's existence also signals that at least one major PE shop has completed its fund close and is now in active hunting mode, which typically cascades; when one firm moves, three others accelerate diligence on overlapping targets to avoid being shut out.

Watch for 13D filings from known PE-affiliated entities in the next 30-45 days, particularly activists who front-run buyout processes by accumulating 5-9% stakes and then demanding board seats or strategic reviews. Also monitor unusual options activity; buyout rumors drive call volume in names with thin float, creating signals 10-15 trading days before formal bids. The spread between the four stocks' current trading prices and their 52-week highs will narrow if the market believes the screen has legs; any name still down more than 20% from its high after two weeks of awareness likely has structural issues the screen missed.

The screen was published April 1, which is either unfortunate timing or deliberate misdirection. Either way, PE deployment schedules do not care about calendar superstition. The funds need exits by 2028-2030, which means they need entries now.